Medicus 2014;23(2):93-98
98
29. WorldHealthOrganization. Cancer PainRelief. Geneva: WorldHealthOr-
ganization,1986.
30. The BritishPain Society –Cancer PainManagement. Dostupno na: http:/
. Datum pristupa: 3. 3.
2014.
31. MeldrumM.Theladderandtheclock:cancerpainandpublicpolicyatthe
endofthetwentiethcentury.JPainSymptomManage2005;29:41–54.
32. AhmedzaiS,BrooksD.Transdermalfentanylversussustained-releaseoral
morphine in cancer pain: preference, efficacy, and quality of life. J Pain
SymptomManage1997;13:254–61.
33. MiguelR.Interventionaltreatmentofcancerpain:thefourthstepintheWorld
HealthOrganizationanalgesicladder?CancerControl.2000;7:149–56.
34. Vadalouca A, Moka E, Argyra E, Sikioti P, Siafaka I. Opioid rotation in pa-
tientswithcancer:areviewoftheliterature.JOpioidManag2008;4:213–50.
35. Nersesyan H, Slavin KV. Current approach to cancer pain management:
Availabilityandimplicationsofdifferenttreatmentoptions.TherClinRisk
Manag2007;3:381–400.
36. Eisenberg E, Marinangeli F, Birkahahn J, Paladini A, Verrassi G. Time to
modifytheWHOanalgesicladder?PainClinicalUpdates2005;13:1–4.
37. Ripamonti CI, Bandieri E, RoilaF.Management of cancer pain: ESMOCli-
nicalPracticeGuidelines.AnnalsofOncology2011;22Suppl6:69-79.
38. Joint Formulary Committee. BritishNational Formulary. 55. izd. London:
BritishMedicalAssociationandRoyalPharmaceuticalSocietyofGreatBri-
tain,2007.
39. McNicol E, Strassels S, Goudas L, Lau J, Carr DB. NSAIDs or paracetamol,
alone or combined with opioids, for cancer pain (Cochrane Review). Co-
chraneDatabaseSystRev2005;1:CD005180.
40. RuoffG, LemaM. Strategies inpainmanagement: newandpotential indi-
cations for COX-2 specific inhibitors. J Pain SymptomManage 2003;25Su-
ppl2:S21–31.
41. Haegerstam GAT. Pathophysiology of bone pain: a review. Acta Orthop
Scand2001;72:308–17.
42. Morales E, Mucksavage JJ. Cyclooxygenase-2 inhibitor-associated acute
renal failure: case report with rofecoxib and review of the literature. Phar-
macotherapy2002;22:1317–21.
43. Eisenberg E, Berkey CS, Carr DB, Mosteller F, Chalmers TC. Efficacy and
safety of nonsteroidal antiinflammatory drugs for cancer pain: a me-
ta-analysis.JClinOncol1994;12:2756–65.
44. AgencyforHealthcareResearchandQuality.EvidenceReport/Technology
Assessment:Number352001.
45. Ventafridda V, Tamburini M, Caraceni A i sur. A validation study of the
WHOmethodforcancerpainrelief.Cancer1987;59:850–856.
46. MarinangeliF,CiccozziA,LeonardisMisur.Useofstrongopioidsinadvanced
cancerpain:arandomizedtrial.JPainSymptomManage2004;27:409–416.
47. Maltoni M, Scarpi E, Modonesi C i sur. A validation study of the WHO
analgesic ladder: a two-step vs three-step strategy. Support Care Cancer
2005;13:888–894.
48. MercadanteS,PorzioG,FerreraPisur.Lowmorphinedosesinopioid-naïve
cancerpatientswithpain.JPainSymptomManage2006;31:242–247.
49. RipamontiC,BandieriE.Cancerpain.CritRevOncolHematol2009;70:145–
149.
50. Ripamonti C, Bareggi C. Pharmacology of opioid analgesia: clinical princi-
ples.U:BrueraE,PortenoyRK(ur.).CancerPain.AssessmentandManage-
ment,Vol.11.Cambridge:CambridgeUniversityPress2010;195–229.
51. GutsteinHB,AkilH.2001.Opioidanalgesics.U:HardmanJGandLimbrid
E(ur.).GoodmanandGilman’sthePharmacologicalBasisofTherapeutics.
10.izd.NewYork:McGraw-HillProfessional,pp.569–619.
52. ChapmanSL,Byas-SmithMG,ReedBA.Effectsofintermediate-andlong-
termuse of opioids on cognition inpatientswith chronic pain. Clin J Pain
2002;18Suppl4:S83–90.
53. AlvarezV, Arttamangkul S,Williams JT. ARAVEabout opioidwithdrawal.
Neuron.2001;32:761–63.
54. Vargas-SchafferG.IstheWHOanalgesicladderstillvalid?Twenty-fourye-
arsofexperience.CanFamPhysician2010;56:514–517.
55. LussierD,PappagalloM.10mostcommonlyaskedquestionsabouttheuse
ofopioidsforchronicpain.TheNeurologist2004;10:221–24.
56. Collins SL, Moore RA, McQuay HJ i sur. Antidepressants and anticonvul-
sants for diabetic neuropathy and postherpetic neuralgia: a quantitative
systematicreview.JPainSymptomManage2000;20:449–58.
57. Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home
palliativecare.SupportCareCancer2001;9:386–89.
58. Guzman J, Esmail R, Karjalainen K i sur. Multidisciplinary rehabilitati-
onforchroniclowbackpain:systematicreview.BritishMedicalJournal
2001;322:511–516.
59. Douglas E. Exercise in cancer patients. Physical Therapy Reviews
2005;10:71–88.
60. Simmonds M. Physical function and physical performance in patients
with pain: what are the measures and what do theymean? U: Max M, ur.
Pain1999anupdatedreview.Refreshercoursesyllabus.Seattle:IASPpress,
1999:127–136.
61. Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer pa-
tients: a systematic review of controlled trials. Cancer Causes Control
2004;15:1035–1056.
62. McQuayHJ,CollinsS,CarrollDisur.Radiotherapyforthepalliationofpa-
infulbonemetastases.CochraneDatabaseSystRev2008;2:CD001793.
Prof. dr. sc. Renata Dobrila-Dintinjana, dr. med.
Klinika za radioterapiju i onkologiju,
KBC Rijeka, 51000 Rijeka, Krešimirova 42
e-mail:
19. 1. 2014.
26. 2. 2014.
ADRESA ZA DOPISIVANJE:
PRIMLJENO/RECEIVED:
PRIHVAĆENO/ACCEPTED:
Dobrila-Dintinjana R.
